Search

Start Over Keyword MEK 1/2 INHIBITOR

  • Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib

    Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib
    Authors:Olivia Campagne, St. Jude Children’s Research HospitalKee Kiat Yeo, Dana-Farber/Boston Children’s Cancer and Blood Disorders CenterJason Fangusaro, Emory UniversityClinton F Stewart, St. Jude Children’s Research Hospital
    Date:2020
    Publisher:ADIS INT LTD
    Publication Version:Author Accepted Manuscript (After Peer Review)